On September 12 and 13, 2023, DEA hosted public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. Click below if you missed the first day’s live session!
